CHEBI:68595

{
    "@context": "/terms/",
    "@id": "/treatments/4c546c60-4d6a-4ff4-a794-6e538ea1bc63/",
    "@type": [
        "Treatment",
        "Item"
    ],
    "aliases": [
        "pankbase-consortium:treatment_Telaprevir_100miG_ml"
    ],
    "amount": 100,
    "amount_units": "mg/mL",
    "audit": {},
    "award": {
        "@id": "/awards/U24DK138512/",
        "component": "data coordination"
    },
    "biosamples_treated": [],
    "creation_timestamp": "2025-05-06T20:47:47.270853+00:00",
    "depletion": false,
    "description": "An oligopeptide consisting of N-(pyrazin-2-ylcarbonyl)cyclohexylalanyl, 3-methylvalyl, octahydrocyclopenta[c]pyrrole-1-carboxy, and 3-amino-N-cyclopropyl-2-oxohexanamide residues joined in sequence. Used for treatment of chronic hepatitis C virus genotype 1 infection.",
    "lab": {
        "@id": "/labs/pankbase-consortium/",
        "title": "Pankbase Consortium, PanKbase"
    },
    "purpose": "stimulation",
    "release_timestamp": "2025-06-15T06:27:09.847164+00:00",
    "schema_version": "7",
    "status": "released",
    "submitted_by": {
        "@id": "/users/5e3038c4-baa5-4589-b3d8-ad2fe634e826/",
        "title": "Ying Sun"
    },
    "submitter_comment": "https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:68595",
    "summary": "Treatment of 100 mg/mL telaprevir",
    "treatment_term_id": "CHEBI:68595",
    "treatment_term_name": "telaprevir",
    "treatment_type": "chemical",
    "uuid": "4c546c60-4d6a-4ff4-a794-6e538ea1bc63"
}